1 In the rat, intracerebroventricular (i.c.v.) injection of cadmium, a pollutant with long biological halflife, causes a sustained increase in blood pressure at doses that are ineective by peripheral route. Since cadmium inhibits calcium-calmodulin constitutive nitric oxide (NO) synthase in cytosolic preparations of rat brain, this mechanism may be responsible for the acute pressor action of this heavy metal.
Introduction
Cadmium is a toxic environmental pollutant, derived from industrial re®ning operations and cigarette smoking. Its very long biological half-life is responsible for nearly irreversible accumulation in the human organism (Nordberg, 1984) . Blood and tissue cadmium concentrations reportedly correlate with blood pressure (BP) levels in man (Glauser et al., 1976; Templeton & Cherian, 1983; Fontana & Boulos, 1988; Whittemore et al., 1991) , though this relationship was not con®rmed by recent epidemiological studies (Staessen & Lauwerys, 1993) .
Cadmium administration, by the oral or intraperitoneal route, is able to increase blood pressure levels in rats (Perry et al., 1977; Revis, 1977; Balaraman et al., 1989) . Recently, we found that cadmium, at doses not sucient to induce pressor eects by the peripheral route, is able to induce sustained BP increases when injected by the intracerebroventricular (i.c.v.) route (Madeddu et al., 1993 ). Yet, the mechanism responsible for this central cardiovascular response has not been elucidated. Heavy metals, including cadmium, have been found to interact with transmembrane calcium in¯ux in the central nervous system (SNC) (Suszkiw et al., 1984) . Consistent with this possibility is our ®nding that central administration of calcium antagonists protects against the pressor eect of cadmium in rats (Madeddu et al., 1993) . On entering neuronal cells, cadmium could act as an`analogueantagonist' of calcium on intracellular receptors. In this regard, there is evidence that cadmium can substitute for calcium in binding neuronal calmodulin, thus aecting the activity of enzymes that are calcium-calmodulin regulated (Haberman et al., 1983; Cheung, 1984) . One of such enzymes, nitric oxide synthase, isoform I (cNOS I ), is constitutively expressed in the brain, spinal cord, sympathetic ganglia, adrenal glands and peripheral nitrergic nerves (Bredt et al., 1990) . Following agonistic-induced elevation of intracellular calcium and in the presence of speci®c cofactors, neural cNOS I catalyzes the conversion of L-Arginine (L-Arg) to nitric oxide (NO) plus L-citrulline (Knowles et al., 1989) . A vasodilator action of NO generated in the CNS is suggested by the ®nding that central injection of NOS inhibitors increases systemic BP and enhances sympathetic nerve activity (El Karib et al., 1993; Toda et al., 1993; Harada et al., 1993; Dominiczak & Bohr, 1995; Cabrera & Bhor, 1995) .
Based on these observations, we hypothesized that the pressor response to central administration of cadmium is due to inhibition of brain calcium-calmodulin-dependent cNOS I , leading to reduction in the generation of NO and unbalanced prevalence of tonic pressor mechanisms. To test this possibility, we determined if the pressor response to cadmium is prevented by i.c.v. pretreatment with L-Arg (the natural substrate for NO biosynthesis), 3-[4-morpholinyl]-sydnonimine-hydrochloride (SIN-1; an NO donor) and CaCl 2 (a cofactor of brain calcium-calmodulin-dependent cNOS I ). In addition, the levels of L-citrulline, the stable equimolar product derived from the enzymatic cleavage of L-Arg by NOS, were determined in the brain of vehicle-or cadmium-treated rats.
Methods

Animals
Male Wistar rats (Morini, Milan, Italy) weighing 280 to 300 g were housed at constant temperature (24+18C) and humidity (60+3%) with a 12 h light/dark cycle and had free access to water and rat chow. All procedures complied with the standards for care and use of animal subjects as stated in Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Academy of Sciences, Bethesda, Md, U.S.A.). In addition, all protocols were approved by the Institutional Animal Care and Research Advisory Committee at the University of Sassari.
Surgical procedures
Rats were anaesthetized with ketamine chloridrate (45 mg kg 71 body weight, Parke-Davis, Milan, Italy) and diazepam (5 mg kg 71 body weight, Roche, Milan, Italy). A 22 gauge stainless steel cannula ®tted into a 364 mm membranevalve plastic block (Umberto Danuso, Milan, Italy) was placed stereotaxically into the left lateral cerebral ventricle (1.5 mm lateral and 1.0 mm posterior to the bregma, and 4.5 mm deep from the skull surface). The plastic block was anchored to the skull with screws embedded in dental acrylic cement. At the end of the surgical procedure ampicillin (1.25 mg in 5 ml saline) was injected by the i.c.v. route to prevent infection.
Four days later, a polyethylene catheter (PE-10 connected to a PE-50, Clay Adams, Parsippany, NJ, U.S.A.) was ®lled with heparin-treated saline and passed into the abdominal aorta via the left femoral artery; the catheter was then tunnelled under the skin and brought out of the back of the neck.
Blood pressure measurement and drug delivery
Experiments were performed in unanaesthetized rats, placed in cylindrical plastic restrainers, 5 days after cerebroventricular cannula implantation. Mean BP (MBP) and heart rate (HR) were measured via the femoral catheter by the use of a Statham transducer (Gould, Oxford, Calif., U.S.A.) connected to a four channel Quartet Recorder (Ugo Basile, Biological Research Apparatus, Comerio, Italy). Injections via the cerebroventricular cannula were performed with a 25 ml syringe (Hamilton, Reno, NV, U.S.A.); injection volume for drug delivery was 5 ml, followed by additional 5 ml saline tō ush the cannula. At the end of the experiment, the correct placement of the cerebroventricular cannula was tested by determining the dipsogenic and pressor response to i.c.v. angiotensin II.
Experiment 1: MBP eects of i.c.v. L-Arg, SIN-1 or CaCl 2
After 15 min stabilization, rats (n=4, each group) received an i.c.v. injection of saline (vehicle), L-Arg (1 mM), SIN-1 (2.42 mM) or CaCl 2 (1 mM). MBP was measured during the stabilization period and for an additional 25 min after i.c.v. administration of the above compounds.
Experiment 2: eects of L-Arg, D-Arg, SIN-1 or CaCl 2 on the pressor response to i.c.v. cadmium acetate After 15 min of stabilization, rats received an i.c.v. bolus injection of saline (vehicle, n=11), D-Arg (1 mM, n=5), L-Arg (1 mM, n=11), SIN-1 (0.48, 1.21 and 2.42 mM, n=8, 8 and 12, respectively), or CaCl 2 (0.1, 0.3 and 1 mM, n=8, 8 and 11, respectively). Five min later, cadmium acetate (88 nM) was injected by the i.c.v. route. MBP and HR were measured during the stabilization period before the cadmium acetate injection and then for an additional 20 min.
Additional experiments were performed to determine if the pressor eects of other agents were attenuated by SIN-1, CaCl 2 or L-Arg. Rats received vehicle, 2.42 mM SIN-1, 1 mM CaCl 2 or 1 mM L-Arg by the i.c.v. route (n=8 each group). Five min later, they were injected with 25 nM 5-hydroxytryptamine (5-HT), intracerebroventricularly. In a separate set of experiments, rats received vehicle or 2.42 mM SIN-1 by the i.c.v. route (n=6 each group). Five min later they were injected with 2 nM angiotensin II, intracerebroventricularly. MBP and HR were measured before and after the injection of 5-HT or angiotensin II.
Finally, the eect of i.c.v. S-nitroso-N-acetyl-penicillamine (SNAP, 1.21 mM, n=5) on the pressor response to cadmium acetate was tested. MBP was measured in basal conditions, before the cadmium acetate injection and then for an additional 5 min.
Experiment 3: eects of i.c.v. cadmium acetate on L-citrulline levels in the brain Rats (n=6 per group) were instrumented with an i.c.v. cannula as described above. Five days later, they were given an i.c.v. bolus injection of vehicle (saline), cadmium acetate (88 nM), L-Arg (1 mM), D-Arg (1 mM), N G -nitro-L-arginine-methyl-ester (L-NAME, 1 mM), L-Arg+cadmium acetate, or D-Arg+cadmium acetate. Ten minutes later, the rats were killed by cervical dislocation and brains were quickly removed and placed on ice. Selected regions (pons, hippocampus, striatus, hypothalamus, cerebral cortex) were homogenized at 48C in a solution of methanol/water (80/20, vol/vol) with an Elvehim Glass Te¯on Homogeniser; 100 ml of the homogenate was used to measure protein concentration. The remaining was sonicated with a microtip Brenson Soni®er (at 75% of maximum power) and then centrifuged at 12,500 g for 10 min at 48C. The supernatants were desiccated in a vacuum speed centrifuge and stored at 7208C until L-citrulline assay.
Analytical procedures
L-Citrulline was measured by o-phthaldialdehyde precolumn derivatization, reversed-phase high-performance liquid chromatography (h.p.l.c.) and¯uorimetric detection (CurroÂ et al., 1996) . The L-citrulline derivative was analysed with a Li-Chrosphere 100 RP-18 column (Merck, Darmstadt, Ger-many). The chromatography was performed with a linear gradient (¯ow rate of 1.3 ml min 71 ) starting with 0.05 M aqueous potassium dihydrogen phosphate, pH 6.3, and ending after 15 min with acetonitrile:H 2 O:methanol (4:4:2). The latter solvent was continued for 5 min and the column was then reequilibrated for 5 min with the initial buer before the infection of the next sample. The h.p.l.c. system (Jasco, Tokyo, Japan) consisted of a 880-PU pump, a 880-02 controller for gradient programming, a Rheodyne injection valve 7125i with a 100 ml ®lling loop and 821-FP spectrouorometer. Excitation/emission wave lengths were maintained at 330/450 nm. The detector was coupled to a CR6A Chromatopak (Shimadzu, Kyoto, Japan). The chemicals utilized were of analytical grade and the solvents were of chromatographic grade.
Statistical analysis
All data are expressed as mean+s.e.mean. Multivariate repeated-measures analysis of variance was performed to test interaction between time and grouping factor. Then univariate analysis of variance was used to test for dierences between groups and over time. Changes caused by the pretreatments were included in the analysis. Dierences within or between groups were determined by Student's paired or unpaired t tests with the Bonferroni multiple comparison adjustment. A probability (P) value less than 0.05 was considered signi®cant.
Substances
Cadmium acetate and calcium chloride were purchased from Aldrich Chemical Company (Milan, Italy); SIN-1 was kindly donated by Cassella AG (Frankfurt/Main, Germany), angiotensin II, 5-HT, L-Arg, D-Arg, SNAP, and L-NAME were purchased from Sigma Chemical Company (Milan, Italy). All these compounds were dissolved in sterile saline immediately before the experiment.
Results
Experiment 1: MBP eects of i.c.v. L-Arg, SIN-1 or CaCl 2 Basal MBP did not signi®cantly dier between the groups at the end of stabilization period (Vehicle: 123+2, L-Arg: 120+4, SIN-1: 117+2, CaCl 2 : 126+7 mmHg). Injection of saline or L-Arg by the i.c.v. route did not aect MBP ( Figure  1 ). Central administration of CaCl 2 decreased MBP levels by 12 mmHg at 25 min (from 126+7 to 114+6 mmHg, P50.05), though this change did not dier from that observed in controls given i.c.v. saline (from 123+2 to 120+2 mmHg). MBP increased transiently following i.c.v. SIN-1 (from 117+2 to 135+2 mmHg at 1 min, P50.05). It returned to basal levels within 5 min and then remained similar to that of vehicle-treated rats until 21 min, when a mild but signi®cant fall in MBP was detected (P50.05). No signi®cant change in HR was observed in any group over the duration of the experiment.
Experiment 2: eects of L-Arg, SIN-1 or CaCl 2 on the pressor response to i.c.v. cadmium acetate During the period that preceded the administration of cadmium acetate, no signi®cant dierence in MBP and HR was detected between the groups given vehicle, L-Arg or D-Arg. Central injection of cadmium induced a prompt and sustained increase in MBP that peaked at 5 min (43+4 mmHg) and lasted over 20 min (Figure 2 ). The main phase of the pressor response to cadmium was signi®cantly attenuated in rats pretreated with L-Arg or D-Arg (32+3 mmHg and 27+5 at 5 min, respectively, P50.05). In addition, L-Arg was able to attenuate the delayed pressor response to cadmium, while D-Arg was ineective. The bradycardia evoked by cadmium was not altered by pretreatment with L-Arg or D-Arg. MBP was transiently increased by i.c.v. SIN-1 (Figure 3 ). It returned to levels similar to baseline at time 0, when cadmium acetate was injected. The pressor response to cadmium was attenuated by SIN-1 and the magnitude of this eect was doserelated (43+4, 43+3, 32+3 and 15+4 mmHg at 5 min with 0, 0.48, 1.21, and 2.42 mM, respectively, P50.05). The bradycardia induced by cadmium was nulli®ed by i.c.v. pretreatment with 2.42 mM SIN-1.
Pretreatment with SNAP, another NO donor, signi®cantly attenuated the pressor eect of cadmium (21+2 versus 43+4 mmHg in controls at 5 min, P50.05).
The pressor response to cadmium was attenuated by i.c.v. CaCl 2 in a dose-related manner, as shown in Figure 4 . The cadmium-induced bradycardia was nulli®ed by pretreatment with CaCl 2 .
Immediately before the administration of 25 nM 5-HT, MBP and HR levels did not dier signi®cantly between rats given vehicle, L-Arg (1 mM), CaCl 2 (1 mM) or SIN-1 (2.42 mM). The pressor response and the bradycardia evoked by the i.c.v. administration of 5-HT were signi®cantly reduced by i.c.v. pretreatment with CaCl 2 , while they were not aected by L-Arg, or SIN-1 ( Figure 5) .
Pretreatment with 2.42 mM SIN-1 did not alter the pressor response and the bradycardia induced by the i.c.v. administration of 2 nM angiotensin II ( Figure 6 ). Experiment 3: eects of i.c.v. cadmium acetate on Lcitrulline levels in the brain L-Citrulline levels in the brain were reduced in rats given i.c.v. cadmium acetate compared with controls (Table 1) . The between group-dierence was highest in pons, followed by striatus, hypothalamus, hippocampus and cortex. The brain L-citrulline levels of rats given L-Arg were higher compared with controls, whereas they were unaltered in rats given D-Arg and reduced in rats treated with L-NAME. L-Arg signi®cantly attenuated the reduction in brain Lcitrulline levels induced by i.c.v cadmium, whereas D-Arg did not.
Discussion
The present study con®rms our previous results that central injection of cadmium increases the BP of rats. The ®nding that the same dose is ineective by the peripheral route indicates that central mechanisms are responsible for the pressor eect induced by this heavy metal (Madeddu et al., 1993) .
The presence of cNOS 1 has been recognized in the rat and bovine brain (Knowles et al., 1989) . This enzyme was subsequently puri®ed, cloned, sequenced and found to be expressed (Bredt et al., 1990) . Levels of brain cNOS 1 expression are altered in the two-kidney, one clip model of hypertension (Kruko et al., 1995) . Most important is the ®nding that the central administration of NOS inhibitors, functioning as false substrates, causes an elevation in rat BP at doses that are ineective by the intravenous route (El Karib et al., 1993; Toda et al., 1993; Harada et al., 1993) . These studies suggest that NO generated in the brain causes a centrally mediated vasodilatation. In fact, the i.c.v. administration of NO donors decreases the BP of normotensive rats, as does i.c.v. CaCl 2 , which stimulates the cNOS 1 to release NO in a cardiovascular regulatory centre (Cabrera & Bhor, 1993) . Consistent with the above ®ndings are our results showing modest, but signi®cant decreases in BP following the central injection of CaCl 2 or SIN-1. The vasodepressor response to SIN-1 was preceded by a brief increase in BP. It appears unlikely that this brief increase in pressure is related to elevated NO levels in the brain, as it was not observed with SNAP, another NO-donor (P. Madeddu, unpublished observations). Our ®nding that the central administration of L-Arg does not aect the basal BP levels of conscious rats con®rms previous experiments performed in anaesthetized, baroreceptor denervated rats (Togashi et al., 1992) . It is conceivable that, under basal conditions, endogenous L-Arg is not a rate-limiting step in NO production by cNOS 1 . However, exogenously supplied L-Arg attenuates the pressor eect induced by NOS inhibitors injected into the lateral cerebral ventricle or into the brain stem nuclei of rats and rabbits (Togashi et al., 1992; Tseng et al., 1996) . We speculated that the brain cNOS 1 might play a role in the acute pressor response to cadmium. The reason for testing this hypothesis was that cadmium, as well as other heavy metal cations, inhibits cNOS 1 activity in the cytosolic preparation from rat brain (Joshi & Desaiah, 1994; Mittal et al., 1995) . Possible mechanisms for this action include: (1) direct binding to the catalytic site(s), (2) interference with the electron transfer during catalysis, or (3) induction of unfavourable conformational changes in the enzyme structure. In addition, cadmium may compete with calcium, that is required for the activation of cNOS 1 , either by antagonizing transmembrane calcium in¯ux or by substituting for it in calmodulindependent enzymatic reactions (Haberman et al., 1983; Suszkiw et al., 1984; Cheung, 1984) . Our results indicate that cadmium-induced pressor eect is mediated, at least in part, by inhibition of brain NOS. Consistent with this possibility is the recognition of decreased levels of L-citrulline in the brain of cadmium-treated rats. L-Citrulline is the stable equimolar derivative of cNOS 1 enzymatic reaction on L-Arg and its reduction indirectly re¯ects the rate of NO production (CurroÂ et al., 1996) . Indeed, we found that i.c.v. administration of L-NAME, an NOS inhibitor, actually lowers the levels of Lcitrulline in the brain, while administration of L-Arg increases them. It is still possible that the lower levels of L-citrulline are, at least in part, the consequence of an accelerated metabolism of L-citrulline and conversion to L-Arg. Yet, this metabolic pathway has been demonstrated only in endothelial cells, where it could help maintain sucient levels of L-Arg during periods of prolonged NO release (Hecker et al., 1990) . However, enzymes responsible for L-citrulline conversion to L-Arg have not been recognized in the CNS. An additional note of consciousness is necessary when considering that, as predicted from studies in other areas of body, L-citrulline might be derived from metabolic pathways other than brain NOS.
Another important ®nding supporting our hypothesis is that the supply of exogenous NO achieved by i.c.v. pretreatment with NO donors attenuates the pressure response to cadmium. The eect of NO donors on the pressor response evoked by cadmium largely exceeded the ability of these compounds to lower BP levels in basal conditions. In addition, selectivity of the eect of SIN-1 is documented by its failure to alter the response to other vasoconstrictors, such as angiotensin II and 5-HT.
In the present study, calcium, a cation that simulates cNOS 1 to release NO, was also used as a probe to prevent the pressor response to cadmium. Antagonism of the response evoked by i.c.v. cadmium was directly proportional to the dose of calcium. This eect could be attributable to competition between calcium and cadmium for entering the neural cell as well as for interacting with calmodulin-NOS complex (Habermann et al., 1983; Suszkiw et al., 1984; Cheung, 1984) . However, the eect of calcium was not selective since we found that the pressor change evoked by another centrally acting vasoconstrictor, 5-HT, was also abolished by calcium.
Availability of L-Arg could be a rate-limiting factor for NO biosynthesis in tissues that were deprived of substrate or during administration of substrate analogues (Hecker et al, 1990; Togashi et al., 1992; Tseng et al., 1996) . In these conditions, administration of exogenous L-Arg normalizes the rate of NO formation and prevents or reverses the increase in BP induced by pharmacological inhibition of NOS. We determined if an excess of exogenous L-Arg can attenuate the pressor response to cadmium, using D-Arg as a control. Interestingly, two phases can be recognised in the pressor response to i.c.v. cadmium: a rapid increase in MBP, that peaks at 5 min, followed by a secondary pressor eect starting at 15 min (Madeddu et al., 1993) . It is noteworthy that D-Arg (which is not a substrate for NOS) attenuated the main phase of the pressor response to cadmium. At variance with its Disomer, L-Arg was able to aect both phases of the pressor response. Cadmium could interact with some regulatory site(s) of cNOS 1 to cause retardation of the catalytic site (Mittal et al., 1995) . The administration of exogenous L-Arg, leading to a large excess of substrate, might have determined more favourable kinetic conditions, which could attenuate the delayed pressor response to cadmium. However, an interesting problem has arisen by the discrepancy between the clear increase in NOS activity (on average 69%) induced by i.c.v. L-Arg ± as measured by L-citrulline levels in the brain ± and the rather weak eect of L-Arg on the pressor response to cadmium, also with regard to the pronounced preventive eect of calcium and NO donors. It is possible that increases in NO release larger than that obtained by administration of exogenous L-Arg are necessary to prevent the pressure response evoked by cadmium, completely. Such large increases in brain NO levels could have been achieved following the administration of NO donors. Additional h.p.l.c. analysis, i.e. -10 -8 -6 -4 -2 0 2 4 6 8 10 12 14 AII SIN-1 Vehicle Figure 6 Eects of intracerebroventricular angiotensin II (AII, 2 nM) on (a) the mean blood pressure (MBP) and (b) heart rate (HR) of unanaesthetized Wistar rats pretreated with vehicle or SIN-1 (2.42 mM). Rats received vehicle or SIN-1 by the i.c.v. route (n=6 each group). Five minutes later, they were injected with angiotensin II. Values are expressed as mean and represent absolute changes from baseline values recorded at the end of stabilization period (time, 75 min); vertical lines show s.e.mean. Table 1 Eects of cadmium, L-arginine, D-arginine or L-NAME on citrulline levels in the brain
Group
Pons Hippocampus Striatus Hypothalamus Cortex
Vehicle Cadmium L-Arginine D-Arginine L-NAME Cadmium+L-arginine Cadmium+D-arginine measuring the levels of L-citrulline in the presence of D-Arg, cadmium plus L-Arg, and cadmium plus D-Arg, was performed to investigate whether NOS activity can be restored by pretreatment with the natural substrate or its D-isomer. The ®nding that L-Arg normalized L-citrulline levels in cadmiumtreated rats, whereas it proved to be marginally active in reversing the BP response, strongly suggests that there is at least one other mechanism in addition to NOS inhibition which is responsible for the pressor eect evoked by cadmium. Such a possibility is supported by the ®ndings that (1) D-Arg was able to attenuate the pressor action of cadmium, but it failed to alter the cadmium-induced reduction in brain Lcitrulline levels, and (2) the pressor response to cadmium exceeded that obtained with central administration of NOS inhibitors, despite the fact that the latter compounds almost nullify NO formation. The discrepancy between functional and biochemical data implies that the central NO system is much more complex than anticipated. The pressor response to cadmium was associated with re¯ex bradycardia, indicating integrity of barore¯ex function in this model. These results may also suggest that the eect of cadmium is mediated by a pressor brain peptide not causing sympathoexcitation. Re¯ex bradycardia was less in magnitude in rats pretreated with CaCl 2 or SIN-1, possibly because of the ability of these agents to attenuate the pressor response to cadmium.
After the discovery that analogues of L-Arg increase BP by inhibiting brain NOS, our ®ndings demonstrate a novel experimental model produced, at least in part, by interference with central NO production. Though the brain NO system has been implicated in the regulation of cardiovascular function, no data are available regarding a cause-eect relationship between alteration in central NO formation and hypertension, neither is it known if chronic low-level exposure to cadmium can aect the activity of NOS in endothelial cells and/or in the CNS. In this regard, we want to stress that the aim of the present study was to evaluate one of the mechanisms implicated in the central pressor response to cadmium and not its relevance in the pathogenesis of human essential hypertension.
In conclusion, our data indicate that the acute pressor eect of i.c.v. cadmium is due, at least in part, to reduced NO formation in the brain. Accumulation of cadmium in the CNS could interfere with various mechanisms (including NOS) implicated in the central regulation of cardiovascular function.
